TipRanks
Go Ultimate55% OFF

Pondy Oxides & Chemicals Ltd. (POCL) AI Stock Analysis

IN:POCL

Pondy Oxides & Chemicals Ltd.

(NSE:POCL)

Select Model
Rating:59Neutral
Price Target:INR 396.00â–¼(-0.30% Downside)
Action:reiterated
Date:10/22/26

Financial performance is the primary driver with solid growth and balance sheet strength tempered by cash flow weakness; bearish technical signals further limit the score while valuation remains moderately supportive for a growth-oriented stock.

Positive Factors
Strong Revenue GrowthRapid revenue expansion indicates stronger business scale and demand across the company’s lead and lead-alloy activities. If sustained, this growth can improve operating leverage, support reinvestment, and strengthen the company’s position in industrial and battery-related end markets over the next several quarters.
Negative Factors
Weak Cash ConversionPersistent negative operating and free cash flow means reported earnings are not consistently converting into available cash. This can increase funding needs during expansion, restrict internally financed investment, and raise liquidity and execution pressure if working-capital demands or reinvestment remain elevated.

Pondy Oxides & Chemicals Ltd. (POCL) vs. iShares MSCI India ETF (INDA)

-30%-20%-10%0%10%20%IN:POCL-24.07%INDA-12.02%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
INR 30.33B
Dividend Yield
0.50%
Average Volume (3M)
51.75K
Price to Earnings (P/E)
24.9
Beta (1Y)
2.16
Revenue Growth
48.57%
EPS Growth
57.30%
Country
India
Employees
492
Sector
General
Sector Strength
55
Industry
Chemicals - Specialty

Pondy Oxides & Chemicals Ltd. Business Overview & Revenue Model

Company Description

Pondy Oxides And Chemicals Limited (POCL), an Indian enterprise founded in 1995 and based in Chennai, operates primarily as a secondary lead smelting company. It focuses on the manufacturing and distribution of various lead metals and alloys, along w...

Pondy Oxides & Chemicals Ltd. Financial Statement Overview

Summary

Robust revenue growth and strong balance sheet with declining leverage are offset by recent negative operating cash flows and margin volatility.

Income Statement

72Positive

Balance Sheet

88Very Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue32.90B29.58B20.57B15.41B14.76B14.55B
Gross Profit2.88B2.83B2.15B769.89M1.74B1.57B
EBITDA2.24B2.15B1.05B748.22M1.11B820.36M
Net Income1.43B1.32B580.55M318.72M750.51M482.48M
Balance Sheet
Total Assets09.83B7.37B4.82B4.73B3.30B
Cash, Cash Equivalents and Short-Term Investments110.43M109.02M398.90M298.50M7.79M7.50M
Total Debt01.52B1.13B1.03B1.56B1.07B
Total Liabilities-7.88B1.95B1.45B1.24B2.08B1.22B
Stockholders Equity7.88B7.88B5.93B3.57B2.65B2.08B
Cash Flow
Free Cash Flow1.04B-1.00B-1.70B284.84M-321.28M492.77M
Operating Cash Flow1.17B-498.89M-810.03M653.05M784.85M632.13M
Investing Cash Flow-273.41M-539.93M-678.59M-528.27M-1.09B-143.65M
Financing Cash Flow-344.63M748.27M1.77B-18.58M301.00M-482.25M

Pondy Oxides & Chemicals Ltd. Technical Analysis

Technical Analysis SentimentNegative
Last Price397.20

Price Trends

50DMA455.20Negative
100DMA491.28Negative
200DMA493.93Negative

Market Momentum

MACD-18.74Positive
RSI36.73Neutral
STOCH21.71Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:POCL, the sentiment is Negative. The current price of 397.20 is below the 20-day moving average (MA) of 422.98, below the 50-day MA of 455.20, and below the 200-day MA of 493.93, indicating a bearish trend. The MACD of -18.74 indicates Positive momentum. The RSI at 36.73 is Neutral, neither overbought nor oversold. The STOCH value of 21.71 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:POCL.

Pondy Oxides & Chemicals Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:POCL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:ROSSARIIN:ROSSARI65NeutralINR 22.12B14.48―0.13%19.76%11.74%
IN:POCLIN:POCL59NeutralINR 30.30B24.87―0.50%48.57%57.30%
IN:BALAMINESIN:BALAMINES58NeutralINR 57.16B27.90―0.63%11.08%34.10%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:TATVAIN:TATVA55NeutralINR 38.49B61.11―0.12%49.69%254.75%
IN:NEOGENIN:NEOGEN46NeutralINR 65.47B163.88―0.05%18.00%3.85%
IN:SUDARSCHEMIN:SUDARSCHEM46NeutralINR 78.99B108.61―0.96%90.13%-6.80%

* General Sector Average

Performance Comparison

0%50%IN:POCLIN:BALAMINESIN:NEOGENIN:ROSSARIIN:SUDARSCHEMIN:TATVADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IN:POCL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:POCLPondy Oxides & Chemicals Ltd.397.20-141.86-26.32%
IN:BALAMINESBalaji Amines Limited1764.15351.1024.85%
IN:NEOGENNeogen Chemicals Ltd.2179.35717.5649.09%
IN:ROSSARIRossari Biotech Ltd399.25-242.58-37.79%
IN:SUDARSCHEMSudarshan Chemical Industries Limited992.15-150.79-13.19%
IN:TATVATatva Chintan Pharma Chem Limited1645.45235.4016.69%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 22, 2026